Prot #CA224047: A Randomized Double-Blind Phase 2/3 Study of Relatlimab Combined with Nivolumab versus Nivolumab in Participants with Previously Untreated Metastatic or Unrsectable Melanoma

Project: Research project

Status	Finished
Effective start/end date	3/21/19 → 3/21/22

Project Details